LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹109 Cr | ₹106 Cr | ₹107 Cr | ₹133 Cr | ₹145 Cr |
What is the latest Total Non-Current Assets ratio of LYKA LABS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹109 Cr |
| Mar2024 | ₹106 Cr |
| Mar2023 | ₹107 Cr |
| Mar2022 | ₹133 Cr |
| Mar2021 | ₹145 Cr |
How is Total Non-Current Assets of LYKA LABS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹109 Cr | 2.42 | |
| Mar2024 | ₹106 Cr | -1.04 | |
| Mar2023 | ₹107 Cr | -19.56 | |
| Mar2022 | ₹133 Cr | -7.73 | |
| Mar2021 | ₹145 Cr | - | |
Compare Total Non-Current Assets of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹271.3 Cr | 1.3% | -5.1% | -51.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,626.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,758.0 Cr | -1.6% | -0.4% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,021.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹122,046.0 Cr | 1% | -0.9% | -1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,086.0 Cr | 0.4% | 0.9% | -8.9% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 1.3% |
-5.1% |
-51.1% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses